Upon multivariate analysis , non-HER@-gene gains independently predicted for shorter disease-free survival ( DFS ) and overall survival ( OS ) in patients with triple-negative cancer , as compared to luminal and HER@-positive tumors ( interaction p = @ for DFS and p = @ for OS ) .